# LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

> **NCT02631772** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 32 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir/Ledipasvir x 12 weeks
- **DRUG:** Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks

## Key facts

- **NCT ID:** NCT02631772
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631772, "LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02631772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*